Plant Allergies: October 2006 Archives

evolutecLONDON (AFX) - Evolutec Group plc, a biopharmaceutical company developing products for the treatment of allergic, inflammatory and autoimmune diseases, said its hay fever drug candidate rEV131 has demonstrated an additional mechanism that may give it anti-inflammatory properties.

It said rEV131, currently in Phase IIb trial, has an equivalent impact to an experimental small molecule H4 receptor blocker which may explain its anti-inflammatory effects, such as the significant reduction in nasal congestion observed, in previous clinical trials in asthma.

'We believe that rEV131 has the potential to fill the unmet need in allergic rhinitis for a new product which has a fast onset and reduces all symptoms,' it said.

Evolutec also said it is on schedule to deliver the results of its North American 300-patient Phase IIb hay fever trial by the year-end.


Herbal remedies may give relief from allergies


It was a very promising article, until I read till the end and saw

Save $84.50 a year off our newsstand price: Subscribe today for only 38 cents a day!

This has almost put me off a little, and I had to re-read the article. What's wrong with people who are actually writing something worth reading? Why there always has to be something distracting and repulsing?

Anyways, I invite you to read the article about the herbal treatment which can help you to fight your allergy.

Allergy study skips shots and goes for the tongue


Finally some good news on Allergy treatment. Sublingual Immunotherapy instead of shots. No more skin penetrating and direct injections into the blood. The allergen will go via "normal" way, i.e. the immune system will get proper warning and will act accordingly

"I have to remember to take it every morning," Mrs. Pilarski said. "Other than that, it's very convenient."

Ok, I understand that there's a price to pay for the safe medicine - a need to remember to take it. However, I think it's not that hard.

Anyways, I think this is a great start.

Read more below

By Shahina Maqbool, 13 Oct 2006

ISLAMABAD: Unpredictable weather changes, respiratory viral infections, and unprecedented heat and humidity in August and September increased the misery of respiratory allergy and asthma patients throughout Punjab and parts of NWFP.

The management of their illness becomes a challenge in Ramazan for many allergy and asthma patients as the holy month is associated with a significant change in daily routine patterns. Many believers visit mosques more frequently during Ramazan than any other time of the year. They expose themselves to dust from carpets, and many experience difficulty in breathing during 'sajda' (kneeling).

Tablet that could cure hay fever


Hayfever: Blights the lives of one in four Britons each summerA daily tablet that could cure hay fever will be available within months.

The pills, which dissolve under the tongue, dramatically reduce the symptoms of the allergy which blights the lives of one in four Britons each summer.

Manufacturer, Danish drug firm ALK-Abello, believes its Grazax tablets, which can be taken at home, will even cure some sufferers.

The prescription-only pills, which are based on grass pollen, have recently been licensed for use and are expected to be on sale in the UK within three months.

Popped under the tongue once a day during the summer, they are the first tablets to tackle the underlying course of hay fever, rather than merely treat the symptoms.

High-efficiency air filtration equipment 100 times more efficient than standard paper filters can be added to existing central air conditioning and heating systems to remove 99.98 percent of airborne allergens.

Southlake, TX (PRWEB) October 13, 2006 -- Autumn brings crisp days and cool evenings to North Texas, a welcome change from the grueling heat of a sizzling summer. It also brings a few things not so welcome – runny noses, watery eyes, itchy throats, sneezing and congestion that are classic symptoms of seasonal allergies.

The Asthma and Allergy Foundation of America (AAFA) again has named the Dallas/Fort Worth area one of the 10 worst places in the United States for fall allergies, which dulls the fall luster for many North Texas residents.

Seasonal Allergy Alert


NBC -- Changing leaves and cooler temperatures aren't the only signs that Autumn is here! For many people, itchy eyes and runny noses mark the beginning of Fall.

But if you depend on a drug store remedy to ease your allergy suffering, you may want to take a second look at the label.

For millions, the start of fall means much more than the end of mowing season!

Americans accustomed to the seasonal misery of sneezing, runny noses and itchy, watery eyes caused by ragweed pollen might one day benefit from an experimental allergy treatment that not only requires fewer injections than standard immunotherapy, but leads to a marked reduction in symptoms that persists for at least a year after therapy has stopped, according to a new study in the October 5 issue of i The New England Journal of Medicine (NEJM). The research was sponsored by the Immune Tolerance Network, which is funded by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), both components of the National Institutes of Health (NIH), and the Juvenile Diabetes Research Foundation International.

The NEW ENGLAND JOURNAL OF MEDICINE (Vol. 355, October 5, 2006, No.14), today reported that a new approach to allergy therapy not only reduced the acute allergic responses of individuals with ragweed allergies but also sustained that effect for over 12 months. The novel treatment, called "AIC" in the paper, is a TLR9 agonist linked to ragweed allergen, developed by Dynavax Technologies Corporation (Nasdaq: DVAX).

Allergic rhinitis (AR), more commonly known as "hay fever" can have a profound impact on the daily lives of sufferers beyond its physical effect -- including psychological well-being, sleep quality, and ability to learn and process cognitive input, according to a new article scheduled to appear in the on-line issue of Allergy and Asthma Proceedings.

"The Burden of Allergic Rhinitis," authored by Robert A. Nathan, M.D., Clinical Professor of Medicine, Department of Internal Medicine, Division of Allergy and Immunology, University of Colorado Health Sciences Center, provides an overview of the impact of AR in our society based on findings in the landmark 2006 Allergies in America Survey (AIA) and other noteworthy surveys and studies conducted in the US and Europe. In his article, Dr. Nathan describes the negative cascade of events that adults and children can experience as a result of this condition.

full story